Literature DB >> 31353536

Prenatally diagnosed developmental abnormalities of the central nervous system and genetic syndromes: A practical review.

Ignatia B Van den Veyver1.   

Abstract

Developmental brain abnormalities are complex and can be difficult to diagnose by prenatal imaging because of the ongoing growth and development of the brain throughout pregnancy and the limitations of ultrasound, often requiring fetal magnetic resonance imaging as an additional tool. As for all major structural congenital anomalies, amniocentesis with chromosomal microarray and a karyotype is the first-line recommended test for the genetic work-up of prenatally diagnosed central nervous system (CNS) abnormalities. Many CNS defects, especially neuronal migration defects affecting the cerebral and cerebellar cortex, are caused by single-gene mutations in a large number of different genes. Early data suggest that prenatal diagnostic exome sequencing for fetal CNS defects will have a high diagnostic yield, but interpretation of sequencing results can be complex. Yet a genetic diagnosis is important for prognosis prediction and recurrence risk counseling. The evaluation and management of such patients is best done in a multidisciplinary team approach. Here, we review general principles of the genetic work-up for fetuses with CNS defects and review categories of genetic causes of prenatally diagnosed CNS phenotypes.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2019        PMID: 31353536     DOI: 10.1002/pd.5520

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Geographic distribution of live births and infant mortality from congenital anomalies in Brazil, 2012-2017.

Authors:  Luzivan Costa Reis; Wesley Luciano Kaizer; Juliano André Boquett
Journal:  J Community Genet       Date:  2021-01-26

2.  Genomic architecture of fetal central nervous system anomalies using whole-genome sequencing.

Authors:  Ying Yang; Sheng Zhao; Guoqiang Sun; Fang Chen; Tongda Zhang; Jieping Song; Wenzhong Yang; Lin Wang; Nianji Zhan; Xiaohong Yang; Xia Zhu; Bin Rao; Zhenzhen Yin; Jing Zhou; Haisheng Yan; Yushan Huang; Jingyu Ye; Hui Huang; Chen Cheng; Shida Zhu; Jian Guo; Xun Xu; Xinlin Chen
Journal:  NPJ Genom Med       Date:  2022-05-13       Impact factor: 6.083

3.  Application of Single Nucleotide Polymorphism Microarray in Prenatal Diagnosis of Fetuses with Central Nervous System Abnormalities.

Authors:  Xiaorui Xie; Xiaoqing Wu; Linjuan Su; Meiying Cai; Ying Li; Hailong Huang; Liangpu Xu
Journal:  Int J Gen Med       Date:  2021-08-06

4.  Prenatal exome sequencing: A useful tool for the fetal neurologist.

Authors:  Maayke A de Koning; Mariëtte J V Hoffer; Esther A R Nibbeling; Emilia K Bijlsma; Menno J P Toirkens; Phebe N Adama-Scheltema; E Joanne Verweij; Marieke B Veenhof; Gijs W E Santen; Cacha M P C D Peeters-Scholte
Journal:  Clin Genet       Date:  2021-10-19       Impact factor: 4.296

5.  Evaluation of prenatal central nervous system anomalies: obstetric management, fetal outcomes and chromosome abnormalities.

Authors:  Ann Gee Tan; Neha Sethi; Sofiah Sulaiman
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-15       Impact factor: 3.007

Review 6.  CNS Malformations in the Newborn.

Authors:  Kristin Barañano; Irina Burd
Journal:  Matern Health Neonatol Perinatol       Date:  2022-01-17

7.  Applicability of a semiautomated volumetric approach (5D CNS+™) for detailed antenatal reconstruction of abnormal fetal CNS anatomy.

Authors:  Amrei Welp; Michael Gembicki; Christoph Dracopoulos; Jann Lennard Scharf; Achim Rody; Jan Weichert
Journal:  BMC Med Imaging       Date:  2022-09-02       Impact factor: 2.795

8.  Detection of submicroscopic chromosomal aberrations by chromosomal microarray analysis for the prenatal diagnosis of central nervous system abnormalities.

Authors:  Tingting Song; Ying Xu; Yu Li; Li Jia; Jiao Zheng; Yinghui Dang; Shanning Wan; Yunyun Zheng; Jianfang Zhang; Hong Yang
Journal:  J Clin Lab Anal       Date:  2020-07-16       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.